Background Image
Table of Contents Table of Contents
Previous Page  337 / 1266 Next Page
Information
Show Menu
Previous Page 337 / 1266 Next Page
Page Background

Systemic therapy: blood-brain barrier

Gerstner et al. Nat Rev Clin Oncol 2009

Tumor-derived

mediators of BBB

disruption:

• VEGF

• Nitric oxide (NO)

• Leukotrienes

• Prostaglandins